Skip to content
MedsAcross

Medicine

Verapamil 10 mg/4 mL injection

Verapamil · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Verapamil 10 mg/4 mL injection is a generic prescription medicine for intravenous use, made by 15 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77° F). Protect from light by retaining in…

Key facts

Active ingredient (INN)
Verapamil
Brand
Sold under the generic name
Strength
10 mg/4 mL
Dosage form
Injection
Route
Intravenous
Packs
5 vials of 4 mL, 1 vial of 4 mL, 25 vials of 4 mL and 20 more
Manufacturers
EugiaIndiaMicro LabsIndiaZydus LifesciencesIndiaAvet PharmaceuticalsIndiaCaplin SterilesIndiaGland PharmaIndiaLifestar PharmaIndiaHealthFirstSomerset TherapeuticsAmneal Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77° F). Protect from light by retaining in package until ready to use.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C08DA01 Verapamil
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
31 March 2005
Identifiers
RxCUI 1665061, 1665057, 898316DailyMed set ID 2d595d9d-af88-474d-b622-d63d786f06a7, 1076a3ef-de02-487f-8117-b4e80495db29, df77b8d1-1d2b-4fea-a1e9-153bd25008a6 +16NDC 72485-109, 23155-912, 70756-606 +16Application ANDA211370, ANDA215829, ANDA214653 +8

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
5 vial in 1 carton / 4 mL in 1 vial70710-1644-5Zydus LifesciencesIndia22 October 2020
5 vial in 1 carton / 4 mL in 1 vial70771-1602-5Zydus LifesciencesIndia22 October 2020
5 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose23155-912-41Avet PharmaceuticalsIndia15 January 2025
5 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose65145-114-05Caplin SterilesIndia16 January 2025
1 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose55150-343-01EugiaIndia6 July 2020
5 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose55150-343-05EugiaIndia6 July 2020
25 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose55150-343-25EugiaIndia6 July 2020
5 vial in 1 carton / 4 mL in 1 vial68083-448-05Gland PharmaIndia15 October 2020
5 vial in 1 carton / 4 mL in 1 vial70756-606-05Lifestar PharmaIndia16 June 2022
1 vial in 1 carton / 4 mL in 1 vial42571-313-86Micro LabsIndia4 March 2019
5 vial in 1 carton / 4 mL in 1 vial42571-313-96Micro LabsIndia24 April 2019
5 vial in 1 carton / 4 mL in 1 vial70121-1586-3Amneal Pharmaceuticals17 July 2018
5 vial in 1 carton / 4 mL in 1 vial72485-109-05Armas Pharmaceuticals1 January 2020
5 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose43066-035-05Baxter Healthcare25 March 2020
5 vial in 1 carton / 4 mL in 1 vial0409-1144-02Hospira30 April 2005
5 vial in 1 carton / 4 mL in 1 vial25021-312-04Sagent Pharmaceuticals15 March 2021
5 vial in 1 carton / 4 mL in 1 vial70069-272-05Somerset Therapeutics18 June 2018
25 vial in 1 carton / 4 mL in 1 vial70069-272-25Somerset Therapeutics18 June 2018
1 syringe, plastic in 1 carton / 4 mL in 1 syringe, plastic51662-1270-1HealthFirst1 September 2018
4 mL in 1 vial51662-1398-1HealthFirst17 October 2019
4 mL in 1 vial, single-dose51662-1548-1HealthFirst20 May 2022
4 mL in 1 vial51662-1685-1HealthFirst18 June 2018
1 box in 1 bag / 1 syringe in 1 box / 4 mL in 1 syringe0404-9968-04Henry Schein10 January 2022

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 12 August 1981Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Verapamil

Clinical summary

Verapamil is a calcium channel blocker indicated for the treatment of supraventricular tachyarrhythmias, including rapid conversion to sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (Wolff-Parkinson-White [WPW] and Lown-Ganong-Levine [LGL] syndromes). MedsAcross supplies Verapamil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Verapamil

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Verapamil 10 mg/4 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.